Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like Spark Therapeutics Further Expands Gene Therapy Expertise With Appointment Of As Chief Scientific Officer September 24, 2017 1-Year old Biotech Startup LifeOmic to Create 225 Jobs at New HQ December 4, 2017 Flex Pharma To Report Second Quarter 2017 Results On August 2, 2017 July 25, 2017
Spark Therapeutics Further Expands Gene Therapy Expertise With Appointment Of As Chief Scientific Officer September 24, 2017
